Raiffeisen Bank International’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.02M Sell
10,251
-4,011
-28% -$1.7M 0.05% 216
2026
Q1
$6.7M Buy
14,262
+681
+5% +$343K 0.1% 165
2025
Q4
$6.43M Sell
13,581
-363
-3% -$169K 0.08% 168
2025
Q3
$5.89M Buy
13,944
+8,673
+165% +$3.36M 0.08% 168
2025
Q2
$1.97M Sell
5,271
-1,375
-21% -$495K 0.03% 221
2025
Q1
$2.27M Buy
6,646
+2,674
+67% +$860K 0.04% 211
2024
Q4
$1.19M Buy
+3,972
New +$1.39M 0.02% 256

Other funds holding HCA

Raiffeisen Bank International's HCA Position: Q2 2026 in Review

Raiffeisen Bank International reduced its HCA Healthcare (HCA) stake by 28% in Q2 2026, selling an estimated $1.7M and leaving 10,251 shares worth $4.02M. The position accounts for 0.05% of the portfolio, ranked #216.

Raiffeisen Bank International first reported a position in HCA in Q4 2024 and has held it in 7 quarters since. The position peaked at $6.7M in Q1 2026. 1,333 funds tracked by Wall St. Rank hold HCA as of Q2 2026.

  • Raiffeisen Bank International held 10,251 shares of HCA Healthcare worth $4.02M as of Q2 2026.
  • Raiffeisen Bank International sold 4,011 HCA Healthcare shares in Q2 2026, an estimated $1.7M.
  • HCA Healthcare made up 0.05% of Raiffeisen Bank International's portfolio in Q2 2026, its #216 holding.
  • Raiffeisen Bank International first reported a position in HCA Healthcare in Q4 2024 and has held it in 7 quarters since.
  • Raiffeisen Bank International's HCA Healthcare position peaked at $6.7M in Q1 2026.
  • 1,333 funds tracked by Wall St. Rank held HCA Healthcare as of Q2 2026.

Based on Raiffeisen Bank International's 13F filing for Q2 2026, filed 3 Aug 2026.